VPAG Investment Fund

Market Access

Under the VPAG agreement, £400 million is available under the VPAG Investment Fund. But what benefits will stay once funding goes away in 2029?

Oncology

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.